Naya Biosciences, Stock Performance
| NAYA Stock | 0.98 0.04 4.26% |
On a scale of 0 to 100, NAYA Biosciences, holds a performance score of 5. The firm secures a Beta (Market Risk) of 2.49, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, NAYA Biosciences, will likely underperform. Please check NAYA Biosciences,'s downside variance and the relationship between the kurtosis and period momentum indicator , to make a quick decision on whether NAYA Biosciences,'s current price movements will revert.
Risk-Adjusted Performance
5 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in NAYA Biosciences, are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, NAYA Biosciences, sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences - StockTitan | 10/14/2024 |
2 | NAYA Biosciences Announces Initiation of Phase 12a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma | 10/24/2024 |
3 | NAYA Biosciences to Present Translational Insights to Support Phase IIIa Clinical Trials for its GPC3-Targeting NK Engager Bispecific Antibody at the 2024 Annua... | 10/31/2024 |
4 | NAYA Biosciences Inc. reports earnings - Quartzy | 11/19/2024 |
NAYA |
NAYA Biosciences, Relative Risk vs. Return Landscape
If you would invest 79.00 in NAYA Biosciences, on September 2, 2024 and sell it today you would earn a total of 19.00 from holding NAYA Biosciences, or generate 24.05% return on investment over 90 days. NAYA Biosciences, is currently generating 0.8741% in daily expected returns and assumes 12.3459% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than NAYA, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
NAYA Biosciences, Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for NAYA Biosciences,'s investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as NAYA Biosciences,, and traders can use it to determine the average amount a NAYA Biosciences,'s price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0708
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | NAYA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 12.35 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.87 actual daily | 17 83% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average NAYA Biosciences, is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NAYA Biosciences, by adding it to a well-diversified portfolio.
About NAYA Biosciences, Performance
By analyzing NAYA Biosciences,'s fundamental ratios, stakeholders can gain valuable insights into NAYA Biosciences,'s financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if NAYA Biosciences, has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if NAYA Biosciences, has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
NAYA Biosciences, is entity of United States. It is traded as Stock on NASDAQ exchange.Things to note about NAYA Biosciences, performance evaluation
Checking the ongoing alerts about NAYA Biosciences, for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for NAYA Biosciences, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| NAYA Biosciences, is way too risky over 90 days horizon | |
| NAYA Biosciences, has some characteristics of a very speculative penny stock | |
| NAYA Biosciences, appears to be risky and price may revert if volatility continues | |
| NAYA Biosciences, was previously known as INVO Bioscience and was traded on NASDAQ Exchange under the symbol INVO. | |
| Latest headline from news.google.com: NAYA Biosciences Inc. reports earnings - Quartzy |
- Analyzing NAYA Biosciences,'s financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NAYA Biosciences,'s stock is overvalued or undervalued compared to its peers.
- Examining NAYA Biosciences,'s industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating NAYA Biosciences,'s management team can have a significant impact on its success or failure. Reviewing the track record and experience of NAYA Biosciences,'s management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of NAYA Biosciences,'s stock. These opinions can provide insight into NAYA Biosciences,'s potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for NAYA Stock analysis
When running NAYA Biosciences,'s price analysis, check to measure NAYA Biosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NAYA Biosciences, is operating at the current time. Most of NAYA Biosciences,'s value examination focuses on studying past and present price action to predict the probability of NAYA Biosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NAYA Biosciences,'s price. Additionally, you may evaluate how the addition of NAYA Biosciences, to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |